Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAPR Capricor Therapeutics Inc

盘前交易 03-16 04:52:38 EDT

30.50

-2.92

-8.74%

盘前30.48

-0.02-0.07%

04:50 EDT

最高33.00	最低29.41	成交量260.67万
今开33.00	昨收33.42	日振幅10.75%
总市值17.50亿	流通市值14.77亿	总股本5,737万
成交额8,034万	换手率5.38%	流通股本4,842万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAPR","market":"US","secType":"STK","nameCN":"Capricor Therapeutics Inc","latestPrice":30.5,"timestamp":1773432000000,"preClose":33.42,"halted":0,"volume":2606721,"hourTrading":{"tag":"盘前","latestPrice":30.48,"preClose":30.5,"latestTime":"04:50 EDT","volume":261,"amount":7952.699753999999,"timestamp":1773651041799,"change":-0.02,"changeRate":-0.000656,"amplitude":0.000328},"delay":0,"changeRate":-0.08737283064033517,"floatShares":48418500,"shares":57370900,"eps":-2.260058,"marketStatus":"盘前交易","change":-2.92,"latestTime":"03-16 04:52:38 EDT","open":33,"high":33,"low":29.408,"amount":80342947.03266,"amplitude":0.107481,"askPrice":30.49,"askSize":22,"bidPrice":29.71,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-2.260058,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773667800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":30.5,"preHourTrading":{"tag":"盘前","latestPrice":30.48,"preClose":30.5,"latestTime":"04:50 EDT","volume":261,"amount":7952.699753999999,"timestamp":1773651041799,"change":-0.02,"changeRate":-0.000656,"amplitude":0.000328},"postHourTrading":{"tag":"盘后","latestPrice":30.0068,"preClose":30.5,"latestTime":"19:39 EDT","volume":9134,"amount":277624.658,"timestamp":1773445169940,"change":-0.4932,"changeRate":-0.01617,"amplitude":0.01617},"volumeRatio":1.0119554350734417,"impliedVol":0.7727,"impliedVolPercentile":0.04},"requestUrl":"/m/hq/s/CAPR","defaultTab":"news","newsList":[{"id":"1120106831","title":"异动解读 | Capricor Therapeutics夜盘大涨5%，因DMD疗法试验成功及启动股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1120106831","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120106831?lang=zh_cn&edition=full","pubTime":"2025-12-05 09:04","pubTimestamp":1764896688,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics Inc（CAPR）今日夜盘大涨5%，引起了市场的广泛关注。消息面上，该公司宣布其实验性细胞疗法deramiocel在一项晚期试验中成功减缓了杜氏肌营养不良症（DMD）的发展速度。这一积极结果显著提升了投资者对该公司未来前景的信心。此外，Capricor Therapeutics还启动了股票发行计划，尽管未披露具体规模，但公司表示募集资金将用于继续开发和生产候选产品，进一步推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"gpt_icon":0},{"id":"1118988587","title":"异动解读 | Capricor Therapeutics盘后大涨5.08%，因DMD疗法试验成功并启动股票发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1118988587","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118988587?lang=zh_cn&edition=full","pubTime":"2025-12-05 05:44","pubTimestamp":1764884678,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics Inc（CAPR）今日盘后股价大涨5.08%，引起了市场的广泛关注。消息面上，该公司宣布其实验性细胞疗法deramiocel在一项晚期试验中成功减缓了杜氏肌营养不良症（DMD）的发展速度。这一积极结果显著提升了投资者对该公司未来前景的信心。此外，Capricor Therapeutics还启动了股票发行计划，尽管未披露具体规模，但公司表示募集资金将用于继续开发和生产候选产品，进一步推动了股价的上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CAPR"],"gpt_icon":0},{"id":"1156698629","title":"Capricor股价六倍增长至40美元，因肌肉疾病细胞疗法达成晚期试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1156698629","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156698629?lang=zh_cn&edition=full","pubTime":"2025-12-03 22:44","pubTimestamp":1764773053,"startTime":"0","endTime":"0","summary":"Capricor股价六倍增长至40美元，因其肌肉疾病细胞疗法达成晚期试验目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"325c9c18f2935f588a39c7d66a8a00d0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"gpt_icon":0},{"id":"1116309654","title":"Capricor高管表示Deramiocel可与任何当前已批准、可用或正在临床开发的治疗药物结合使用","url":"https://stock-news.laohu8.com/highlight/detail?id=1116309654","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116309654?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:37","pubTimestamp":1764769042,"startTime":"0","endTime":"0","summary":"Capricor高管表示Deramiocel可与任何当前已批准、可用或正在临床开发的治疗药物结合使用","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"1177216032","title":"Capricor Therapeutics高管表示公司通过圣地亚哥制造设施的预许可检查","url":"https://stock-news.laohu8.com/highlight/detail?id=1177216032","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177216032?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:26","pubTimestamp":1764768371,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics高管表示公司通过圣地亚哥制造设施的预许可检查","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPR"],"gpt_icon":0},{"id":"1145758240","title":"Capricor Therapeutics宣布Duchenne肌营养不良症治疗药物Deramiocel在Hope-3关键性第三阶段研究中取得积极的顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1145758240","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145758240?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:21","pubTimestamp":1764764470,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics宣布Duchenne肌营养不良症治疗药物Deramiocel在Hope-3关键性第三阶段研究中取得积极的顶线结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"325c9c18f2935f588a39c7d66a8a00d0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"1196171207","title":"Capricor Therapeutics第三季度每股收益为-0.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1196171207","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196171207?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:20","pubTimestamp":1763572836,"startTime":"0","endTime":"0","summary":"11月10日讯 - Capricor Therapeutics第三季度基本每股收益为-0.54美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"2575496265","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.04%报6.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575496265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575496265?lang=zh_cn&edition=full","pubTime":"2025-10-14 00:04","pubTimestamp":1760371496,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日00时04分，Capricor Therapeutics, Inc.股票出现异动，股价大幅下跌5.04%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的治疗方法，用于治疗杜氏肌营养不良症，这是一种罕见的肌肉营养不良症，导致肌肉变性和过早死亡，以及其他医疗需求未得到满足的疾病。Deramiocel目前正在进行治疗杜氏肌营养不良症的3期临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014000456972b9115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014000456972b9115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","CAPR","BK4539","BK4139"],"gpt_icon":0},{"id":"1192104664","title":"Capricor Therapeutics就杜氏肌营养不良症Deramiocel项目在A类会议后发布监管进展更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1192104664","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192104664?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:17","pubTimestamp":1758799035,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics就杜氏肌营养不良症Deramiocel项目在A类会议后发布监管进展更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPR","BK4139"],"gpt_icon":0},{"id":"2518279724","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.15%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518279724?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，Capricor Therapeutics, Inc.股票出现波动，股价急速下跌5.15%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为3087.26%、661.78%、287.22%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039abf3078e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2516378816","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378816","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516378816?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:52","pubTimestamp":1741013572,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时52分，Capricor Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为687.54%、115.08%、86.65%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为163.15%、70.53%、40.78%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032252529637b25c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CAPR"],"gpt_icon":0},{"id":"2514967857","title":"Capricor Therapeutics, Inc.盘中异动 快速下跌5.00%报15.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514967857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514967857?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:52","pubTimestamp":1740585161,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时52分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5442.90%、206.70%、195.43%，振幅较大的相关个股有Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Humacyte Inc C/Wts 27/08/2026 ，振幅分别为161.02%、43.31%、39.47%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262352419893ba47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2513778370","title":"Capricor Therapeutics, Inc.盘中异动 股价大跌5.20%报14.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513778370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513778370?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:56","pubTimestamp":1740409003,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时56分，Capricor Therapeutics, Inc.股票出现异动，股价大幅下跌5.20%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为142.31%、59.62%、25.08%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256449890fc11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242256449890fc11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0},{"id":"2512111193","title":"Capricor Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报15.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512111193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512111193?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:17","pubTimestamp":1739902679,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时17分，Capricor Therapeutics, Inc.股票出现波动，股价快速下挫5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Aditxt, Inc.、Solid Biosciences Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为667.76%、198.57%、164.56%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021759988a21c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219021759988a21c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CAPR","BK4139"],"gpt_icon":0},{"id":"2509323572","title":"Capricor Therapeutics, Inc.盘中异动 早盘快速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509323572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509323572?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:16","pubTimestamp":1738772201,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时16分，Capricor Therapeutics, Inc.股票出现异动，股价快速下挫5.11%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4256.80%、1754.28%、1304.65%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600164196191b62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020600164196191b62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","BK4139","LENZ"],"gpt_icon":0},{"id":"2507717671","title":"Capricor Therapeutics, Inc.盘中异动 下午盘快速上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507717671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507717671?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:36","pubTimestamp":1738262178,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时36分，Capricor Therapeutics, Inc.股票出现波动，股价大幅上涨5.47%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Nutriband Inc C/Wts 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1768.86%、288.24%、236.24%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、63.82%、61.86%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013102361996145887&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013102361996145887&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2503284836","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503284836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503284836?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:02","pubTimestamp":1736953340,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时02分，Capricor Therapeutics, Inc.股票出现波动，股价急速上涨5.00%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Exicure, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为197.30%、121.96%、72.63%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Os Therapies Incorporated、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为68.03%、60.10%、54.40%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152302209867440d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152302209867440d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2493579019","title":"Capricor Therapeutics盘中异动 快速上涨5.05%报13.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493579019","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493579019?lang=zh_cn&edition=full","pubTime":"2024-12-24 04:24","pubTimestamp":1734985493,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时21分，Capricor Therapeutics, Inc.股票出现波动，股价急速上涨5.05%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224042454ab8ed44a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224042454ab8ed44a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2492612717","title":"Capricor Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492612717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492612717?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:11","pubTimestamp":1734369082,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时11分，Capricor Therapeutics, Inc.股票出现异动，股价急速拉升5.02%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011122984c73d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CAPR","LENZ","BK4139"],"gpt_icon":0},{"id":"2491051843","title":"Capricor Therapeutics, Inc.盘中异动 快速跳水5.09%报13.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491051843","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491051843?lang=zh_cn&edition=full","pubTime":"2024-12-14 01:34","pubTimestamp":1734111268,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日01时34分，Capricor Therapeutics, Inc.股票出现波动，股价大幅下跌5.09%。Capricor Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Capricor Therapeutics, Inc.公司简介：Capricor Therapeutics Inc 是一家生物技术公司，专注于推进转化细胞和外泌体疗法，以重新定义罕见疾病的治疗前景。Deramiocel 目前正处于治疗杜氏肌营养不良症的 3 期临床开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214013429ab75dca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CAPR","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.capricor.com","stockEarnings":[{"period":"1week","weight":0.0932},{"period":"1month","weight":0.2603},{"period":"3month","weight":0.1722},{"period":"6month","weight":3.7956},{"period":"1year","weight":1.3847},{"period":"ytd","weight":0.0568}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发基于转化细胞和外泌体的疗法，用于治疗Duchenne肌营养不良症（“DMD”），这是一种罕见的导致肌肉退化和过早死亡的肌营养不良症，以及具有高度未满足的医疗需求的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.12654},{"month":2,"riseRate":0.545455,"avgChangeRate":0.012535},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.01026},{"month":4,"riseRate":0.454545,"avgChangeRate":0.454133},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.152616},{"month":6,"riseRate":0.636364,"avgChangeRate":0.035159},{"month":7,"riseRate":0.363636,"avgChangeRate":0.07472},{"month":8,"riseRate":0.545455,"avgChangeRate":0.008533},{"month":9,"riseRate":0.454545,"avgChangeRate":0.348894},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.099314},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.0945},{"month":12,"riseRate":0.181818,"avgChangeRate":0.280594}],"exchange":"NASDAQ","name":"Capricor Therapeutics Inc","nameEN":"Capricor Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Capricor Therapeutics Inc,CAPR,Capricor Therapeutics Inc股票,Capricor Therapeutics Inc股票老虎,Capricor Therapeutics Inc股票老虎国际,Capricor Therapeutics Inc行情,Capricor Therapeutics Inc股票行情,Capricor Therapeutics Inc股价,Capricor Therapeutics Inc股市,Capricor Therapeutics Inc股票价格,Capricor Therapeutics Inc股票交易,Capricor Therapeutics Inc股票购买,Capricor Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Capricor Therapeutics Inc(CAPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Capricor Therapeutics Inc(CAPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}